XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.22

-5.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (15933)	8/5/2002 3:27:12 PM
From: Cacaito	Read Replies (1) of 17367

Recent psoriasis report is from xoma material, Dna material is still ongoing 500 subjects expected completion by end of the year allowing filing. xomaDna are also running another trial to lear how to get patients OUT of the drug, kind of a weaning dosages trial to avoid roaring back disease. Baxtard sepsis trial, well the pick up of Xigris for treatment is slow, it could be they do not need to go in combo, IF THEY START SOON...soon soon soon...yeah soon soon soon !!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next